Phase 2 Uveal Melanoma Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Uveal Melanoma
Diwakar Davar44 enrolled3 locationsNCT06070012
Recruiting
Phase 2
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
Uveal MelanomaOcular Melanoma
H. Lee Moffitt Cancer Center and Research Institute37 enrolled1 locationNCT05524935
Recruiting
Phase 1Phase 2
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
Uveal MelanomaMetastatic Uveal MelanomaMetastatic Uveal Melanoma in the Liver
St Vincent's Hospital, Sydney8 enrolled2 locationsNCT07063875
Recruiting
Phase 2
Adjuvant Quisinostat in High-Risk Uveal Melanoma
Uveal Melanoma
University of Miami63 enrolled1 locationNCT06932757
Recruiting
Phase 2
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
Uveal Melanoma
California Pacific Medical Center Research Institute40 enrolled1 locationNCT05077280